Acadia Pharmaceuticals | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Acadia Pharmaceuticals USD 822.38M 57.14M 2025-06
ALKERMES USD 1.62B 113M 2025-06
Alnylam Pharmaceuticals USD 250.59M 135.16M 2025-06
Biogen USD 17.63B 655.3M 2025-06
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Corcept Therapeutics USD 635.79M 47.49M 2025-06
Cytokinetics USD -737440000 471.03M 2025-06
Eisai JPY 828.51B 12.91B 2025-06
Eli Lilly USD 18.27B 2.43B 2025-06
Incyte USD 4.17B 503.34M 2025-06
J&J USD 78.11B 6.62B 2025-03
Moderna USD 9.4B 667M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Prothena USD 486.93M 47.44M 2024-12
PTC Therapeutics USD -206546000 20.79M 2025-06
Sarepta Therapeutics USD 1.36B 214.66M 2025-06
Ultragenyx Pharmaceutical USD 151.29M 7.04M 2025-06
Vertex Pharmaceuticals USD 17.18B 679.1M 2025-06


Acadia Pharmaceuticals Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.